Abstract
The poor prognosis of hepatocellular carcinoma (HCC) has been associated with recurrence and metastasis. Recently, we established a pair of HCC cell lines from a primary (H2-P) and its matched metastatic (H2-M) HCC tumors. A high density of cDNA microarray with 9184 human cDNA was used to identify the differentially expressed genes between H2-P and H2-M. Comparing with H2-P, eight upregulated and six downregulated genes were detected in H2-M. One interesting finding is the overexpression of Vimentin (VIM), a well-defined intermediate filament, which has been linked to a more aggressive status in various tumors. The correlation of overexpression of VIM and HCC metastasis was studied by immunohistochemistry using a tissue microarray with 200 primary HCCs and 60 pairs of primary and matched metastatic HCC samples. Tissue microarray demonstrated that the overexpression of VIM was significantly associated with HCC metastasis (P<0.01). This finding strongly suggests that the overexpression of VIM may play an important role in the metastasis of HCC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aguayo A and Patt YZ . (2001). Semin. Oncol., 28, 503–513.
Aldamassi M, Chen Z, Merriman B, Gussin D and Nelson S . A Practical Guide to Microarray Analysis of Gene Expression. UCLA Microarray Core & Nelson Lab, UCLA Department of Human Genetics, Revision #3, September 21, 2001 (available at http://www.genetics.ucla.edu/microarray).
Ben Ze'ev A and Raz A . (1985).Cancer Res., 45, 2632–2641.
Byrne JA, Mattei MG and Basset P . (1996). Genomics, 35, 523–532.
Deo RC, Bonanno JB, Sonenberg N and Burley SK . (1999). Cell, 98, 835–845.
Domagala W, Striker G, Szadowska A, Dukowicz A, Harezga B and Osborn M . (1994). Eur. J. Cancer, 30A, 1527–1534.
Fan C, Stendahl U, Stjernberg N and Beckman L . (1995). Oncology, 52, 498–500.
Gilles C, Polette M, Piette J, Delvigne AC, Thompson EW, Foidart JM and Birembaut P . (1996). J. Pathol., 180, 175–180.
Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM and Birembaut P . (1999). J. Cell Sci., 112, 4615–4625.
Guan X-Y, Zhang HE, Bitter M, Jiang Y, Meltzer PS and Trent JM . (1996). Nat. Genet., 12, 10–11.
Guan X-Y, Fang Y, Sham JST, Kwong DLW, Zhang Y, Liang Q, Li H, Zhou H and Trent JM . (2000). Genes Chromosomes Cancer, 29, 110–116.
Hendrix MJ, Seftor EA, Seftor RE and Trevor KT . (1997). Am. J. Pathol., 150, 483–495.
Iwatsuki H, Sasaki K, Suda M and Itano C . (1999). Acta. Histochem., 101, 369–382.
Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, Bryden AA, Villette JM, Stower MJ and Maitland NJ . (2002). Prostate, 52, 253–263.
Laroia G, Cuesta R, Brewer G and Schneider RJ . (1999). Science, 284, 499–502.
Lelievre V, Pineau N, Hu Z, Ioffe Y, Byun JY, Muller JM and Waschek JA . (2001). J. Biol. Chem., 276, 43668–43676.
Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP and Sauter G . (1999). Am. J. Pathol., 154, 981–986.
Qin L-X, Tang Z-Y, Sham JST, Ma Z-C, Ye S-L, Zhou X-D, Wu Z-Q, Trent JM and Guan X-Y . (1999). Cancer Res., 59, 5662–5665.
Redondo M, Villar E, Torres-Muñoz J, Tellez T, Morell M and Petito C . (2000). Am. J. Pathol., 157, 393–399.
Tang ZY . (2001). World J. Gastroenterol., 7, 445–454.
Thomas-Salgar S, Millis AJ . (1994). J. Biol. Chem., 269, 17879–17885.
Vieira HL, Haouzi D, El Hamel C, Jacotot E, Belzacq AS, Brenner C and Kroemer G . (2000). Cell Death Differ., 7, 1146–1154.
Wang Y, Wu M-C, Sham JST, Tai L-S, Fang Y, Wu W-Q, Xie D and Guan X-Y . (2002). J. Pathol., 197, 610–616.
Wen JM, Huang JF, Hu L, Wang W, Zhang M, Sham JST, Xu J, Zeng W-F, Xie D, Liang L and Guan X-Y . (2002). Cancer Genet. Cytogenet., 135, 91–95.
Acknowledgements
This work was supported by a Research Grant Council Grant HKU7236/00M and Leung Kwok Tze Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hu, L., Lau, S., Tzang, CH. et al. Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 23, 298–302 (2004). https://doi.org/10.1038/sj.onc.1206483
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206483
Keywords
This article is cited by
-
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway
BMC Cancer (2023)
-
Unclear tumor border in magnetic resonance imaging as a prognostic factor of squamous cell cervical cancer
Scientific Reports (2023)
-
Emerging role for R-loop formation in hepatocellular carcinoma
Genes & Genomics (2023)
-
Long Non-coding RNA LINC01503 Promotes Gastric Cardia Adenocarcinoma Progression via miR-133a-5p/VIM Axis and EMT Process
Digestive Diseases and Sciences (2021)
-
Iron elevates mesenchymal and metastatic biomarkers in HepG2 cells
Scientific Reports (2020)